Charles Schwab’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,624
| Closed | -$11.2K | – | 3509 |
|
|
2023
Q4 | $11.2K | Hold |
1,624
| – | – | ﹤0.01% | 3520 |
|
|
2023
Q3 | $10.2K | Hold |
1,624
| – | – | ﹤0.01% | 3562 |
|
|
2023
Q2 | $13.5K | Hold |
1,624
| – | – | ﹤0.01% | 3587 |
|
|
2023
Q1 | $7.15K | Hold |
1,624
| – | – | ﹤0.01% | 3543 |
|
|
2022
Q4 | $9.58K | Hold |
1,624
| – | – | ﹤0.01% | 3532 |
|
|
2022
Q3 | $12K | Hold |
1,624
| – | – | ﹤0.01% | 3503 |
|
|
2022
Q2 | $24K | Buy |
+1,624
| New | +$24K | ﹤0.01% | 3508 |
|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$79K | – | 3613 |
|
|
2021
Q4 | $79K | Buy |
+1,000
| New | +$79K | ﹤0.01% | 3466 |
|